Evaluation of the therapeutic benefit of rPMS applied to the trapezius muscle to treat migraine combined with myofascial pai

Not Applicable

• Conditions: G43; M79; Migraine; Other soft tissue disorders, not elsewhere classified

• Registration Number: DRKS00019870
• Lead Sponsor: Klinikum rechts der Isar der TU München

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-08-01
• Study Start: 2019-11-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Written informed consent; age above 18 years; presence of at least one trigger point within the trapezius muscle; diagnosis of migraine according to the Essener Kopfschmerzfragebogen

Exclusion Criteria

Other neurological diseases (except for migraine); epilepsia; pregnancy; implanted medical devices; other severe diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement of symptoms according to the headache diary of the DMKG (as assessed 90 days before and after rPMS).

Secondary Outcome Measures

Name	Time	Method
Improvement of the peripheral pressure pain threshold of the neck and shoulder musculature (as measured by algometry prior and subsequent to rPMS) & improvement of symptoms according to the MIDAS questionnaire (as assessed 90 days before and after rPMS).